BCG in bladder cancer immunotherapy
S Jiang, G Redelman-Sidi - Cancers, 2022 - mdpi.com
Simple Summary Bacillus Calmette–Guérin (BCG), a live attenuated strain of Mycobacterium
bovis, is the most successful microbial immunotherapy of cancer in current use. Intravesical …
bovis, is the most successful microbial immunotherapy of cancer in current use. Intravesical …
The impact of diagnostic ureteroscopy prior to radical nephroureterectomy on oncological outcomes in patients with upper tract urothelial carcinoma: a comprehensive …
Ł Nowak, W Krajewski, J Chorbińska, P Kiełb… - Journal of Clinical …, 2021 - mdpi.com
Background: The incidence of intravesical recurrence (IVR) following radical
nephroureterectomy (RNU) is reported in up to 50% of patients with upper tract urothelial …
nephroureterectomy (RNU) is reported in up to 50% of patients with upper tract urothelial …
Development and validation of a prognostic model for predicting overall survival in patients with bladder cancer: a SEER-based study
W Wang, J Liu, L Liu - Frontiers in Oncology, 2021 - frontiersin.org
Objective To establish a prognostic model for Bladder cancer (BLCA) based on
demographic information, the American Joint Commission on Cancer (AJCC) 7th staging …
demographic information, the American Joint Commission on Cancer (AJCC) 7th staging …
[HTML][HTML] A narrative review of management of muscle-invasive bladder cancer perioperative period: will continuous and combined treatment be the new trend?
T Lan, S Ran, M Gao, W Li, W He - Translational Andrology and …, 2024 - ncbi.nlm.nih.gov
Methods A non-systematic, literature search was conducted between March 5, 2023 and
November 30, 2023 on PubMed using “perioperative period”,“MIBC”,“chemotherapy”,“ …
November 30, 2023 on PubMed using “perioperative period”,“MIBC”,“chemotherapy”,“ …
The impact of surgical waiting time on oncological outcomes in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy: a systematic …
Ł Nowak, W Krajewski, J Łaszkiewicz… - Journal of Clinical …, 2022 - mdpi.com
Radical nephroureterectomy (RNU) with bladder cuff excision is a standard of care in
patients with high-risk upper tract urothelial carcinoma (UTUC). Although several …
patients with high-risk upper tract urothelial carcinoma (UTUC). Although several …
[HTML][HTML] Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer: results of a multicentric phase II trial
V Fonteyne, P Dirix, C Van Praet, C Berghen… - European Urology …, 2022 - Elsevier
Background High-risk muscle-invasive bladder cancer (MIBC) has a poor prognosis. Old
trials showed that external beam radiotherapy (EBRT) after radical cystectomy (RC) …
trials showed that external beam radiotherapy (EBRT) after radical cystectomy (RC) …
Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?
L Scafuri, A Sciarra, F Crocetto, M Ferro… - Future Science …, 2021 - Taylor & Francis
Although urothelial carcinoma can occur in any part of the urinary tract, 90–95% of urothelial
malignancies arise in the bladder [1]. Conversely, approximately 90% of bladder …
malignancies arise in the bladder [1]. Conversely, approximately 90% of bladder …
[HTML][HTML] Multi-Centre Study of Progression Factors and Intravesical Recurrence in Patients with Urothelial Carcinoma of the Upper Urinary Tract
L García-Morales, FJ Contreras-Matos… - Diagnostics, 2024 - mdpi.com
Background/Objectives: A retrospective analysis was conducted to identify factors
associated with disease progression and intravesical recurrence (IVR) in a multi-centre …
associated with disease progression and intravesical recurrence (IVR) in a multi-centre …
[HTML][HTML] A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant Therapy
GK Harada, SN Seyedin, O Heutlinger, A Azizi… - Advances in Radiation …, 2025 - Elsevier
Purpose Pelvic lymph node metastases (ypN+) after multiagent neoadjuvant chemotherapy
(NAC) is a poor prognostic sign in nonmetastatic muscle-invasive bladder cancer (nmMIBC) …
(NAC) is a poor prognostic sign in nonmetastatic muscle-invasive bladder cancer (nmMIBC) …
Recent advances in immune checkpoint inhibitors in the treatment of urothelial carcinoma: A review
M Kato, J Uchida - International Journal of Urology, 2023 - Wiley Online Library
Abstract Treatment options for urothelial carcinoma were limited until the emergence of
immune checkpoint inhibitors, and even now, the prognosis of metastatic disease is poor …
immune checkpoint inhibitors, and even now, the prognosis of metastatic disease is poor …